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ABSTRACT
Gli3 is a Hedgehog (Hh)-responsive transcription factor that can
function as a transcriptional repressor or activator. We show that Gli3
activity in mouse thymic epithelial cells (TECs) promotes positive
selection and differentiation from CD4+ CD8+ to CD4+ CD8− single-
positive (SP4) cells in the fetal thymus and that Gli3 represses Shh.
Constitutive deletion ofGli3, and conditional deletion ofGli3 fromTECs,
reduced differentiation to SP4, whereas conditional deletion ofGli3 from
thymocytes did not. Conditional deletion of Shh from TECs increased
differentiation to SP4, and expression of Shh was upregulated in the
Gli3-deficient thymus. Use of a transgenic Hh reporter showed that the
Hh pathway was active in thymocytes, and increased in the Gli3-
deficient fetal thymus. Neutralisation of endogenous Hh proteins
in the Gli3−/− thymus restored SP4 differentiation, indicating that Gli3
in TECs promotes SP4 differentiation by repression of Shh.
Transcriptome analysis showed that Hh-mediated transcription was
increased whereas TCR-mediated transcription was decreased in
Gli3−/− thymocytes compared with wild type.
KEYWORDS: Shh, Gli3, Fetal thymus, Positive selection, CD4, T-cell
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INTRODUCTION
Gli3 is a member of the Hedgehog (Hh)-responsive Gli family of
transcription factors, mammalian orthologues of the Drosophila Ci
protein (Ramsbottom and Pownall, 2016). The Gli proteins bind
DNA in a sequence-specific manner, but have evolved different
functions and distinct temporal and tissue-specific expression
patterns. Gli3 can be processed to be a repressor of transcription
(Gli3R) in the absence of Hh signalling, or an activator (Gli3A)
upon Hh signal transduction (Sasaki et al., 1999). During
development it can function before the expression of Hh genes,
independently of Hh. In many tissues, Gli3R limits Shh signalling,
Gli3R and Shh have opposing functions, and Gli3 deficiency and
Shh deficiency result in opposite phenotypes (Hager-Theodorides
et al., 2005; Shah et al., 2004; Solanki et al., 2017; teWelscher et al.,
2002; Wang et al., 2000).
During αβ T-cell development in the thymus, CD4− CD8−
double-negative (DN) cells differentiate to CD4+ CD8+ double-
positive (DP) cells, which give rise to both CD4 single-positive
(SP4) and CD8 single-positive (SP8) populations. Gli3 is expressed
in adult and fetal thymic epithelial cells (TECs) and fetal but not
adult thymocytes, and Gli3 promotes pre-T-cell receptor (TCR)-
induced differentiation from DN to DP cell, and negative selection
of the TCR repertoire (Barbarulo et al., 2016; Hager-Theodorides
et al., 2005, 2009; Saldaña et al., 2016). Here, we investigate Gli3
function during αβ T-cell development in the embryonic thymus at
the transition from the DP to SP cell.
Maturation from DP to SP follows successful rearrangement of
the Tcra locus, and requires TCR signalling: positive selection
results in appropriate MHC restriction of SP cells, followed by
negative selection of potentially self-reactive clones (Klein et al.,
2014; Starr et al., 2003). Many models have been proposed to
describe how DP thymocytes commit to the SP4 and SP8 lineages,
and how positive selection ensures that selected SP4 and SP8
populations express TCR appropriately restricted by MHCII and
MHCI, respectively (Carpenter and Bosselut, 2010; Starr et al.,
2003). The strength and duration of the TCR signal that a
developing cell receives broadly determine its fate, with the
strongest signals leading to negative selection, usually at the SP
stage in the medulla (of TCR recognising self antigens),
intermediate signals leading to positive selection, and weaker
signals or lack of TCR signalling leading to cell death by neglect
(Singer et al., 2008). For DP thymocytes undergoing positive
selection, again TCR signal strength and duration influence SP4 and
SP8 lineage choice. Those cells receiving stronger longer TCR
signals tend towards the SP4 fate, weaker/more transient signals
favour differentiation to SP8 SP, and additionally SP4/SP8 fate
decisions may be influenced by the relative timing of cytokine
signalling and TCR signalling that a developing cell receives
(Bosselut, 2004; Klein et al., 2014; Starr et al., 2003). TCR signal
strength and duration are dependent on avidity of the TCR for its
ligand (and therefore on the TCR sequence), and may also be
affected by other intracellular or extracellular influences on TCR
signal transduction, in addition to cytokines. Thus, local thymic
stromal factors, including Notch and morphogen signalling, may
also influence SP lineage choice and selection (Brugnera et al.,
2000; Crompton et al., 2007; Laky and Fowlkes, 2008; Park et al.,
2010; Takahama, 2006). Several lineage-specific transcription
factors are required for the SP4/SP8 lineage decision, including
ThPok (Zbtb7b), Gata3, Runx1, Runx3 and Mazr (Carpenter and
Bosselut, 2010; Naito et al., 2011). The ways in which the
transcriptional regulation of lineage commitment and differentiation
relate to extracellular signalling molecules and TCR signal
transduction require further study.
In the thymus, Shh is expressed by TECs in the medulla and
corticomedullary junction, and is required for normal medullary
TEC development and maturation (El Andaloussi et al., 2006;
Outram et al., 2000; Sacedón et al., 2003; Saldaña et al., 2016).Received 11 November 2016; Accepted 3 January 2018
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TECs provide MHCpeptide ligands for developing thymocytes and
are required for both positive and negative selection of the TCR
repertoire (Klein et al., 2014).
Gli3R can suppress Hh pathway activation by at least two
mechanisms. First, it can repress the expression of Hh genes in the
Hh-secreting cell, hence reducing the overall Hh protein
Fig. 1. See next page for legend.
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concentration in a tissue. Second, expression of Gli3 in the signal-
receiving cell will be processed to Gli3R in the absence of Hh
proteins, which will transcriptionally repress Hh target genes.
In the thymus stroma, Gli3 has both Hh-independent and Hh-
dependent functions, and Gli3 deficiency leads to Hh-dependent
upregulation of the Hh target gene Gli1 (Hager-Theodorides et al.,
2009). In the fetal thymus, Gli3 deficiency leads to reduced pre-TCR-
induced differentiation from DN to DP, whereas Shh deficiency
leads to the opposite phenotype (Hager-Theodorides et al., 2005;
Rowbotham et al., 2009). Later in T-cell development,Gli3mutation
reduces negative selection and influences the transcriptome of fetal
thymus stromal cells (Hager-Theodorides et al., 2009). Stromally
expressed genes influenced by Gli3 mutation include Hedgehog-
interacting protein (Hhip), Rbp1,Cxcl9 andNos2. This suggested that
Gli3 might influence negative selection through regulation of Nos2
(Hager-Theodorides et al., 2009).
Here we show that Gli3 expressed in TECs promotes positive
selection and maturation from DP to SP T-cell by suppression of
Shh expression in TECs, and that Shh signals directly to developing
T-cells to modulate TCR-mediated signalling and transcription.
RESULTS
Impaired development of mature SP4 T-cells in the Gli3
mutant thymus
Gli3 deficiency is embryonic lethal, so to investigatewhether Gli3 is
required for differentiation of thymocytes from the DP to SP stage,
we cultured wild-type (WT) and Gli3 mutant E17.5 mouse fetal
thymus organ culture (FTOC) for 4 days and assessed changes in
developmentally regulated cell-surface markers. This culture period
enabled us to measure the rate of differentiation of the mature SP
populations, as they are first produced. We observed a significant
gene dose-dependent decrease in the proportion of SP4 cells and in
the SP4:SP8 ratio in the Gli3 mutant FTOC compared with WT
(Fig. 1A,B). The SP4 population was TCRβ+ and TCRγδ− in both
WT and Gli3 mutant thymus (Fig. S1), consistent with normal
divergence of the γδ lineage at the DN stage in the Gli3−/− thymus
(Vantourout and Hayday, 2013). The proportion of CD4− CD8+
cells was significantly increased in Gli3−/− compared with WT
(Fig. 1A,B). This suggests that efficient differentiation from DP to
SP4 cells required Gli3, and that Gli3 deficiency favoured lineage
commitment to SP8 over SP4. However, the embryonic CD8+
CD4− population also contains immature single positive (ISP) cells,
so we gated on the CD3hi population, and analysed the distribution
of DP and SP thymocytes. We found no significant difference in the
proportion of CD3hi thymocytes between WT, Gli3+/− and Gli3−/−
(Fig. 1C,D). Gating on CD3hi cells confirmed the requirement for
Gli3 for normal differentiation from CD3hi DP to CD3hi SP4 cell, as
the proportion of CD3hi DP cells was significantly increased and the
proportion of CD3hi SP4 cells was significantly decreased, whereas
the proportion of the CD3hi SP8 population was not significantly
different between the three genotypes of embryo (Fig. 1E,F).
In order to dissect further the stages of maturity affected by Gli3,
we stained thymocytes for the surface markers CD69, HSA (CD24)
and Qa2. DP thymocytes express high levels of HSA and then
acquire CD69 expression as a result of TCR signalling for positive
selection (Ge and Chen, 1999). Newly positively selected SP
thymocytes also express high levels of HSA and CD69, and as they
mature they downregulate HSA and CD69 and gain expression of
Qa2 (Ge and Chen, 1999; Weinreich and Hogquist, 2008).
The proportion of mature HSA−Qa2+ cells in the SP4 population,
although low in both genotypes, was significantly decreased in
Gli3−/− compared with WT (Fig. 1G,H). CD69 expression was
significantly decreased on DP thymocytes in the Gli3−/− thymus
compared with WT (Fig. 1I,J), indicating that fewer DP cells were
undergoing positive selection, and consistent with the overall
reduction in SP4 maturation. CD69 expression was also on average
lower on theGli3−/− SP4 population thanWT, and there was greater
variation in expression levels in Gli3−/− compared with WT,
suggesting dysregulated maturation in the absence of Gli3.
Positive and negative selection and SP4/8 lineage commitment
are determined by many factors, including transcriptional regulators
of signal transduction and the TCR signal strength itself. A longer
and stronger TCR signal promotes differentiation towards SP4,
whereas a weaker signal favours SP8 (Bosselut, 2004). Since Gli3
deficiency suppressed lineage commitment towards SP4 cells and
biased the SP4:SP8 ratio, we investigated whether the TCR signal
strength was affected in the Gli3 mutant FTOC by measuring cell-
surface CD5 expression, which correlates with TCR and pre-TCR
signal strength (Azzam et al., 2001, 1998). The mean fluorescence
intensity (MFI) of CD5 on the DP, SP4 and SP8 cells was
significantly decreased in the Gli3−/− thymus compared with WT
(Fig. 2A-C). This suggested that reduced TCR signal strength might
be one factor responsible for the decreased commitment to SP4 in
the Gli3 mutant.
Increased Shh signalling in Gli3mutant thymocytes
The Gli3 mutant fetal thymus has increased expression of the Hh
target gene Gli1 in stroma (Hager-Theodorides et al., 2009),
indicating that, overall, Gli3 acts as a repressor of Hh pathway
activation in the stroma. Since Gli3 can repress Shh expression by
repression of an intermediate transcriptional activator of Shh in
other tissues (te Welscher et al., 2002), and Shh is the key Hh ligand
expressed by TECs (Outram et al., 2000; Rowbotham et al., 2007;
Saldaña et al., 2016; Shah et al., 2004), we tested whether more Shh
protein was present in the Gli3-deficient fetal thymus compared
with WT by ELISA. Shh protein was significantly increased in
Gli3−/− compared with WT (Fig. 2D).
To test if Shh was signalling directly to developing T-cells, we
used Gli binding site (GBS)-GFP transgenic (tg) reporter mice to
measure active Hh-dependent transcription in DP, SP4 and SP8
populations in theGli3mutants (Fig. 2E-I). The GBS-GFP-tg express
GFP when activator forms of Gli proteins bind to the GBS transgene
(Balaskas et al., 2012). We observed significant increases in GFP
expression in DP, SP4 and SP8/ISP populations in GBS-GFP-tgGli3
mutants comparedwith GBS-GFP-tgGli3+/+ (Fig. 2E,F). TheMFI of
Fig. 1. T-cell development inGli3+/+,Gli3+/− andGli3−/− E17.5 plus 4 days
in FTOC and E18.5 thymus. Flow cytometry analysis. Scatter plots show
mean±s.e.m. Each point represents thymus from an individual mouse embryo.
(A-H) E17.5 FTOC for 4 days. Gli3+/+ (n=14), Gli3+/− (n=14) and Gli3−/−
(n=11). (I,J) E18.5 Gli3+/+ (n=3) and Gli3−/− (n=3) thymus. (A) CD8 against
CD4. (B) Percentage of populations (relative to mean of WT) giving
significance by Student’s t-test compared with WT for SP4 (Gli3+/−, P<0.03;
Gli3−/−, P<0.001), SP8 (Gli3−/−, P<0.03) and SP4:SP8 ratio (Gli3+/−, P<0.02;
Gli3−/−, P<0.0006). (C) CD3 staining on Gli3+/+, Gli3+/− and Gli3−/−
thymocytes, giving the percentage of CD3hi cells. (D) Percentage of CD3hi
thymocytes in Gli3+/+, Gli3+/− and Gli3−/− (relative to mean of WT littermate).
(E) CD8 against CD4, gated on CD3hi. (F) Percentage of populations gated on
CD3hi, giving significance by Student’s t-test compared with WT for CD3hi SP4
(Gli3+/−, P<0.002;Gli3−/−, P<0.0004), CD3hi SP4:SP8 ratio (Gli3−/−, P<0.002)
and CD3hi DP (Gli3+/−, P<0.05; Gli3−/−, P<0.02). (G) HSA against Qa2
expression, gated on SP4 cells from Gli3+/+ and Gli3−/−. (H) Relative
percentage of HSA− Qa2+ cells in the SP4 population, giving significance by
Student’s t-test compared with WT (P<0.002). (I) Percentage of CD69+ cells in
SP4 and DP populations, giving significance by Student’s t-test for SP4
(P<0.07) and DP (P<0.05). (J) CD69 expression on SP4 and DP cells in a
representative experiment.
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GFP on the SP4, DP and SP8 populations was significantly higher in
Gli3−/− than in Gli3+/+ (Fig. 2G). Gating on CD3hi thymocytes, the
proportion of GFP+ mature CD3hi SP4 cells was significantly higher
in the Gli3 mutants compared with Gli3+/+, and the MFI of CD3hi
SP4 and CD3hi SP8 cells was also significantly increased (Fig. 2H,I).
This increase inGFP expression showed that Hh pathway activation is
Fig. 2. See next page for legend.
4











increased in thymocytes in Gli3−/− and therefore suggests that the
increased Shh protein level is signalling directly to developing T-cells
in the Gli3 mutant thymus.
Attenuation of Hh signalling in Gli3−/− thymus reverses the
decrease in the SP4 population
Since the Gli3-deficient thymus has increased Hh signalling, loss of
Gli3 in the thymus could cause changes that are directly dependent
on the increase in the Hh signal or, alternatively, that are dependent
on Gli3 but independent of the increase in Hh pathway activation.
To investigate whether the differences in the Gli3−/− thymus were
directly due to increased Hh signalling, we attenuated Hh signalling
by treatment with recombinant (r) Hhip to neutralise endogenous
Hh proteins in FTOC. As expected, rHhip-treated WT FTOC had a
higher proportion of SP4 and SP8 cells but a decreased percentage
of DP cells than untreated controls (Fig. 3A,B) (Lau et al., 2017).
rHhip-treated Gli3−/− FTOC had a significantly higher proportion
of SP4 cells (Fig. 3A,B). The mature CD3hi SP4 and CD3hi SP8
populations were significantly increased and the CD3hi DP
population decreased in the rHhip-treated WT FTOC relative to
their controls, whereas in the rHhip-treatedGli3−/− FTOC, although
the mean proportional change in both the CD3hi SP4 and CD3hi SP8
populations was greater than in the WT, only the increase in the
CD3hi SP4 was significant, and variability was greater (Fig. 3C,D).
This increased variability in response to Hh neutralisation in the
Gli3−/− compared with WT suggested that Gli3 might be required
for normal interpretation of changes in the Hh signal.
Neutralisation of Hh proteins also increased cell-surface CD5
expression in WT FTOC (Fig. 3E-G). As expected, the highest cell-
surface CD5 expression was observed in the SP4 population in all
cultures, and gating on CD3hi cells showed that the CD3hi DP
populations expressed lower levels of cell-surface CD5 than theWT
CD3hi SP4 and CD3hi SP8 populations (Fig. 3E). Interestingly,
rHhip treatment significantly increased the MFI of CD5 on the
CD3hi DP population in the Gli3−/− FTOC, whereas in WT FTOC
MFI of CD3hi SP4 and CD3hi SP8 populations was significantly
increased (Fig. 3E-G).
These experiments suggest that the decrease in SP4 differentiation
in theGli3−/− FTOC at this developmental transition is a direct result
of the increase in Shh, but that Gli3 might also be required to respond
to changes in the Shh signal. Consistent with this, previous studies
showed that Shh treatment of WT FTOC decreases the SP4
population, the SP4:SP8 ratio and cell-surface CD5 expression, and
that in mature T-cells constitutive activation of Gli2-mediated
transcription reduces TCR signal transduction (Furmanski et al.,
2015, 2012; Rowbotham et al., 2007). By contrast, constitutive loss of
Shh, Gli1 or Gli2 from fetal thymus increases differentiation from the
DP to SP stage (Drakopoulou et al., 2010; Rowbotham et al., 2007).
Gli3 expression in TECs plays a key role in T-cell
development
We next tested if the changes in thymocyte selection and maturation
were the result of the activity of Gli3 expressed in TECs, rather than
of cell-intrinsic Gli3 activity in developing thymocytes. We
compared fetal thymocyte development in conditional knockouts,
in which Gli3 is conditionally deleted from TECs (Gli3fl/fl
FoxN1Cre+), and in which Gli3 is specifically deleted from all
haematopoietic cells including all thymocytes (Gli3fl/fl VavCre+).
Interestingly, most of the changes observed in the Gli3-deficient
thymus were due to loss of Gli3 expression from TECs.
We first analysed thymocyte development at E17.5, the day on
which mature SP4 cells first arise. Conditional deletion of
thymocyte-intrinsic Gli3 in fresh E17.5 Gli3fl/fl VavCre+ thymus
did not result in significant changes in the proportion of thymocyte
populations or in cell-surface CD5 expression compared with
littermate control thymus (Fig. 4A-D). By contrast, conditional
deletion ofGli3 from TECs inGli3fl/fl FoxN1Cre+ embryos resulted
in a significant decrease in the differentiation of SP4 cells
(Fig. 4E,F). On E17.5, in addition to a significant reduction in the
emerging SP4 population, we observed a significant decrease in the
DP population, and a concomitant increase in the DN population, as
previously described in the constitutive Gli3−/− thymus (Hager-
Theodorides et al., 2005) (Fig. 4E,F). Cell-surface CD5 expression
was significantly lower on the DP and DN cells in Cre+ than in the
control, indicating lower pre-TCR and/or TCR signal strength
(Fig. 4G,H) (Azzam et al., 1998; Rowbotham et al., 2009; Sahni
et al., 2015).
We then cultured E17.5 Gli3fl/fl FoxN1Cre+ and Gli3fl/fl
FoxN1Cre− FTOCs for 4 days to investigate the rate of
differentiation at the transition from DP to SP4 cells (Fig. 4I-M).
Conditional deletion of Gli3 from TECs resulted in a significant
decrease in the proportion of SP4 cells and in the SP4:SP8 ratio, while
the proportion of DP cells significantly increased compared with the
Cre− littermate control (Fig. 4I,K). Gating on CD3hi cells, we
observed a significant decrease in the SP4 population and in the SP4:
SP8 ratio (Fig. 4J,L). Cell-surface CD5 expression was significantly
decreased in the DP population from Gli3fl/fl FoxN1Cre+ FTOC
compared with Cre− littermates (Fig. 4M). By contrast, FTOC from
Gli3fl/fl VavCre+ showed no differences in the rate of differentiation,
distribution of thymocyte subsets, or cell-surface CD5 expression
compared with control, confirming the importance of Gli3 expression
in TECs, rather than in the hematopoietic compartment of the thymus,
for the normal regulation of thymocyte differentiation (Fig. 4N-R).
Since constitutive loss of Gli3 led to Hh-dependent changes in
thymocyte differentiation and maturation, we tested whether the
changes that resulted from conditional deletion of Gli3 specifically
from TECs were also Hh dependent. We treated the Gli3fl/fl
Fig. 2. Expression of CD5 on thymocytes, ELISA for Shh in E17.5 thymus,
and detection of Hh pathway activation in E17.5 WT and Gli3 mutant
thymocytes. (A-C) Flow cytometry analysis of E17.5 FTOC +4 days, with
scatter plots showing relative mean±s.e.m., where each point represents
thymus from an individual embryo from Gli3+/+ (WT; n=14, circles), Gli3+/−
(n=14, squares), Gli3−/− (n=11, triangles). (A) CD5 staining on DP, SP4 and
SP8 populations, showing MFIs from a representative experiment. (B) MFI of
CD5 on SP4, DP and SP8 populations, giving significance by Student’s t-test
compared with WT for SP4 (Gli3+/−, P<0.007; Gli3−/−, P<0.004), DP (Gli3−/−,
P<0.001) and SP8 (Gli3−/−,P<0.004). (C) MFI of CD5, gated onCD3hi on SP4,
DP and SP8, giving significance by Student’s t-test for CD3hi SP4 (Gli3−/−,
P<0.03), CD3hi DP (Gli3−/−,P<0.04) and CD3hi SP8 (Gli3−/−,P<0.04). (D) Shh
protein measured by ELISA in Gli3+/+ (n=3) and Gli3−/− (n=3) E17.5 thymus
(P<0.003). (E-I) Flow cytometry analysis of GFP expression in SP4, DP and
SP8 populations from GBS-GFP-tg E17.5 FTOC +4 days from Gli3+/+ (n=3),
Gli3+/− (n=4) and Gli3−/− (n=3) littermates. Scatter plots show relative mean±
s.e.m., where each point represents thymus from a different embryo. (E) SSC
versus GFP, gated on SP4 (top row), DP (middle row) and SP8 (bottom row)
cells from Gli3+/+ (left), Gli3+/− (middle) and Gli3−/− (right) littermates, with
percentage in region shown. (F) Percentage GFP+, giving significance by
Student’s t-test compared with WT for SP4 (Gli3+/−, P<0.004), DP (Gli3−/−,
P<0.003) and SP8 (Gli3+/−, P<0.02; Gli3−/−, P<0.02). (G) MFI of GFP, giving
significance by Student’s t-test compared with WT for SP4 (Gli3+/−, P<0.003;
Gli3−/−, P<0.02), DP (Gli3−/−, P<0.04) and SP8 (Gli3−/−, P<0.004). (H)
Percentage of GFP+ cells, gated on CD3hi, giving significance by Student’s
t-test comparedwithWT for CD3hi SP4 (Gli3+/−,P<0.006;Gli3−/−,P<0.01) and
CD3hi SP8 (Gli3+/−, P<0.05). (I) MFI of GFP, gated on CD3hi, giving
significance by Student’s t-test compared with WT for SP4 (Gli3−/−, P<0.01)
and SP8 (Gli3+/−, P<0.01; Gli3−/−, P<0.01).
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FoxN1Cre+ FTOCwith rHhip and observed a significant increase in
the SP4 population and a significant decrease in the DN population
compared with untreated FTOC (Fig. 5A,B). Gating on CD3hi cells
also showed that the rHhip-treated Gli3fl/fl FoxN1Cre+ FTOC had
an increased proportion of CD3hi DP cells compared with untreated
controls (Fig. 5C,D). The MFI of CD5 on SP4 and DP cells in the
rHhip-treated Gli3fl/fl FoxN1Cre+ FTOC was significantly
increased compared with the untreated control (Fig. 5E,F). This
was in contrast to the effect of rHhip treatment on constitutiveGli3−/−
FTOC, in which, although rHhip treatment increased the proportion
of SP4 cells, it only increased the MFI of anti-CD5 staining in the
CD3hi DP population (Fig. 3G). As thymocytes in the Gli3fl/fl
FoxN1Cre+ FTOC express Gli3, whereas those in the Gli3−/− FTOC
do not, this difference suggests that Gli3 activity in developing fetal
thymocytes is also required for interpretation of the change in the Shh
signal, when the high Shh signal caused by Gli3 deficiency is
neutralised by rHhip treatment.
Conditional deletion of Shh from TECs (Shhfl/fl FoxN1Cre+) led
to the opposite phenotype to conditional deletion ofGli3 from TECs
(Fig. 5G-L). There was a significant increase in the proportion of
SP4 cells and in the SP4:SP8 ratio, but a significant decrease in the
DP population compared with Cre− control FTOC (Fig. 5G,H). The
proportion of mature CD3hi SP4 cells was also significantly higher,
whereas the proportion of CD3hi DP cells was significantly lower, in
Shhfl/fl FoxN1Cre+ FTOC compared with Cre− controls (Fig. 5G,I).
Treatment of Shhfl/fl FoxN1Cre+ FTOC with rShh reversed this
Fig. 3. Attenuation of Hh signalling by
rHhip treatment of WT and Gli3−/−
FTOCs. (A-G) WT (n=4) and Gli3−/−
(n=6) E17.5 FTOCs were treated with
rHhip or left untreated (control) for
4 days, and analysed by flow cytometry.
(B,D,F,G) Scatter plots show relative
mean±s.e.m., where each point
represents the percentage of SP4
(circles), SP8 (squares) and DP
(crosses) populations of one rHhip-
treated lobe from an individual thymus,
divided by the percentage of that
population from the untreated lobe from
the same thymus. (A,C) Dot plots of (A)
CD8 versus CD4 and (C) CD8 versus
CD4 gated on CD3hi. (B,D) Percentage
of rHhip-treated populations, giving
significance by Student’s t-test
compared with untreated control for (B)
SP4 (WT, P<0.05; Gli3−/−, P<0.03), SP8
(WT, P<0.002), DP (WT, P<0.006); and
for (D) CD3hi SP4 (WT, P<0.04; Gli3−/−,
P<0.05), CD3hi SP8 (WT, P<0.05),
CD3hi DP (WT, P<0.05). (E) Scatter plots
of (left) MFI of CD5 on SP4, DP and SP8
cells and (right) in the same populations
gated on CD3hi from a representative
experiment. (F) MFI of CD5 in Hhip-
treated FTOC on SP4, SP8 and DP
showing significance by Student’s t-test
compared with untreated control for SP4
(WT, P<0.05); and in (G) MFI of CD5
showing significance by Student’s t-test
compared with untreated control on
CD3hi SP4 (WT, P<0.002), CD3hi SP8
(WT, P<0.0001) and CD3hi DP (Gli3−/−,
P<0.05).
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Fig. 4. See next page for legend.
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effect and significantly reduced differentiation to SP4 and CD3hi
SP8 but increased the proportion of CD3hi DP cells (Fig. 5J-L).
Transcriptional mechanisms at the DP to SP transition in the
Gli3-deficient thymus
In order to understand the transcriptional mechanisms by which
Gli3 regulates the DP to SP4 transition and thymic selection, we
performed microarrays on FACS-sorted CD69− DP, CD69+ DP
and SP4 thymocytes from E18.5 WT and Gli3 mutant thymus
(Fig. 6A-C, Fig. S2; GEO accession GSE87499). We identified
differentially expressed genes (DEGs) by Ebayes between Gli3−/−
and WT samples for each sorted population, and used principal
component analysis (PCA) to investigate the datasets in an unbiased
way (Fig. S2, Tables S1 and S2). For each sorted population dataset,
we intersected the 2000 most significant DEGs with the 4000 genes
that contributed most to the principal component (PC) axis in which
Gli3−/− samples segregated from WT, in order to identify genes of
interest.
PCA on the CD69− DP microarray data segregated the samples
by genotype on PC2, which accounted for 19% of variability
(Fig. 6A, Fig. S2A). Interestingly, genes that contributed to PC2,
which were higher in the Gli3−/− samples than in WT, included
many Hh signalling and target genes, consistent with increased Hh
signalling in Gli3−/−. These included Hoxd13, Hoxa13, Hoxd8,
Smoc2, H19, S100a9 and Ihh (Chan et al., 2014; Lu et al., 2015;
Mandhan et al., 2006; Outram et al., 2009; Pazin and Albrecht,
2009). Runx3 and Notch1, which both promote SP8 differentiation
over SP4, also contributed to PC2, with higher expression inGli3−/−
than in WT (Bosselut, 2004; Fowlkes and Robey, 2002). Genes that
contributed to PC2, which were more highly expressed in WT
samples, included genes important in selection and SP4 maturation,
including Map3k1, which is required for positive selection
(Germain, 2002; Xue et al., 2008) (Fig. 6A).
The intersection analysis of the CD69−DP data highlighted 1083
genes, including the Hh target genes Fgf1 and Kif24, the Wnt
pathway activator Bcl9l (Martin, 1998; Sarkar et al., 2010), and
Cd53, which is induced upon a lower affinity TCR-MHC interaction
(Puls et al., 2002). These were more highly expressed in Gli3−/−
than inWT (Fig. 6A, Table S2). In addition, many genes involved in
TCR signalling and apoptosis during repertoire selection were
identified, including Fas, Tcerg1, Ltbr, Pten, Camk4 and Ctcf
(Castro et al., 1996; Heath et al., 2008; Krebs et al., 1997; Montes
et al., 2015; Zhu et al., 2010), all of which showed lower expression
in Gli3−/− than in WT.
PCA on the microarray data from the CD69+ DP population,
which are cells that have received the TCR signal for positive
selection (Ge and Chen, 1999), segregated theGli3−/− samples from
the WT on PC3, which accounted for 20% of variability (Fig. 6B,
Fig. S2B). Again, Hh signalling and target genes, such as Foxa1,
Kif3a, Hdac2 and Tgfb2, contributed to this PC, with higher
expression in Gli3−/− than in WT (Furmanski et al., 2013; Katoh
and Katoh, 2009) (Fig. 6B). By contrast, genes that contributed to
PC3 and were more highly expressed in WT than in Gli3−/− again
included several genes involved in selection and SP4 commitment,
including: Egr2, which is downstream of TCR signalling and
involved in positive selection (Lauritsen et al., 2008); andGata3, an
SP4 commitment gene (Hernández-Hoyos et al., 2003).
The intersection analysis of the CD69+ DP data identified 1150
genes (Fig. 6B), including some known Hh targets, which were
more highly expressed in Gli3−/− than WT, such as Hoxa7, Bmp2,
Tulp3, Itgav and H19 (Chan et al., 2014). Many genes crucial for
thymic selection showed lower expression in Gli3−/− than in WT,
including: Itk, a tyrosine kinase downstream of TCR that is required
for positive selection and the SP4:SP8 lineage decision (Lucas et al.,
2003); Egr1, which is downstream of TCR signalling and involved
in positive selection (Lauritsen et al., 2008); Socs1, the deficiency of
which promotes SP8 differentiation (Ilangumaran et al., 2010);
Anxa5, which promotes apoptosis during negative selection
(Rosenbaum et al., 2011); and Cd6, a co-stimulatory molecule
that interacts with its ligand on TECs to promote differentiation to
SP (Singer et al., 2002).
Finally, we carried out PCA and DEG analysis of the SP4
microarray data. PCA showed that the Gli3−/− SP4 data segregated
from the WT on PC2, which accounted for 22% of variability
(Fig. 6C, Fig. S2). The intersection analysis of the SP4 data
highlighted 703 genes. Egr2 and Nab2, which are required for
selection, Anxa6, which regulates selection-related apoptosis, and
Lef1 and Tox, which promote SP4 lineage commitment and
maturation, were expressed at lower levels in Gli3−/− than in WT
(Collins et al., 2006; Rosenbaum et al., 2011). Nr4a1, Nr4a3 and
Cd5, which are transcriptional targets of TCR signal transduction
with a level of expression that correlates with TCR signal strength,
were also lower in Gli3−/− than in WT (Moran et al., 2011; Sekiya
et al., 2013). Several Hh target genes, such as Itgav, Stmn1, Itga6
and Nedd9, were more highly expressed in Gli3−/− than in WT
(Aquino et al., 2009; Lu et al., 2015) (Fig. 6C).
Since Hh target genes were upregulated in theGli3−/−CD69+ DP
population (which is undergoing positive selection), and the FTOC
experiments suggested that the reduced DP to SP4 transition in the
Gli3−/− thymus was due to increased Hh signalling, we tested
Fig. 4. Gli3 expression in TECs and not thymocyte-intrinsic Gli3
expression is required for SP4 development. (A-D) Flow cytometry of fresh
E17.5Gli3fl/fl VavCre− control (n=7) andGli3fl/fl VavCre+ (n=6) thymus. Scatter
plots show relative mean±s.e.m., where each point represents thymus from a
different embryo for control littermate and Gli3fl/fl VavCre+. (A) CD4 and CD8
expression. (B) Relative percentage of thymocyte subsets. (C) Relative MFI of
anti-CD5 staining on thymocyte subsets. (D) Representative histogram
showing anti-CD5 staining on the DP population in control (solid line) andGli3fl/fl
VavCre+ (dotted line), showing MFIs. No significant differences were found
between control and Cre+ thymi. (E-H) Flow cytometry of fresh E17.5 thymus
fromGli3fl/fl FoxN1Cre− (control, n=4) andGli3fl/fl FoxN1Cre+ (n=4) littermates.
Scatter plots show relative mean±s.e.m., where each point represents thymus
from a different embryo for control and Gli3fl/fl FoxN1Cre+. (E) CD8 against
CD4. (F) Relative mean percentage of SP4, DP, SP8 and DN populations,
giving significance by Student’s t-test compared with control littermate for SP4
(P<0.01), DP (P<0.05) and DN (P<0.04). (G) Representative histogram shows
CD5 staining on DP thymocytes from control (Cre−, solid line) andCre+ (dotted
line). MFI of CD5 fluorescence is given. (H) Relative meanMFI of CD5 on SP4,
DP, SP8 and DN populations. Differences are significant between Cre+ and
control for DP (P<0.03) and DN (P<0.05). (I-M) Flow cytometry analysis of
E17.5 FTOC +4 days from Gli3fl/fl FoxN1Cre− (n=8) and Gli3fl/fl FoxN1Cre+
(n=10) littermates. Scatter plots show relative mean±s.e.m., where each point
represents thymus from a different embryo for control FTOC and Gli3fl/fl
FoxN1Cre+ FTOC. (I) CD8 against CD4. (J) CD8 against CD4, gated on CD3hi.
(K) Relative percentage of SP4, DP and SP8 populations and SP4:SP8 ratio,
with significance by Student’s t-test compared with Cre− littermate for SP4
(P<0.02), DP (P<0.007) and SP4:SP8 ratio (P<0.05). (L) Relative percentage
of thymocyte populations and CD4:CD8 ratio, gated on CD3hi, with
significance compared withCre− littermate, for CD3hi SP4 (P<0.05) and CD3hi
SP4:SP8 ratio (P<0.04). (M) Relative MFI of CD5 on thymocyte populations,
with significance compared with Cre− for DP (P<0.007). (N,O) Flow cytometry
of E17.5 FTOC+4 days from controlGli3fl/flVavCre− (n=7) andGli3fl/fl VavCre+
(n=6) littermates. No significant differences were found between Cre− and
Cre+. (N) CD4 against CD8. (O) CD4 against CD8, gated onCD3hi. (P) Relative
percentage of SP4, DP and SP8 populations and SP4:SP8 ratio. (Q) Gated on
CD3hi, relative percentage of SP4, DP and SP8 populations and SP4:SP8
ratio. (R) MFI of CD5, gated on thymocyte populations.
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whether the transcription of genes required for differentiation to SP
could be modulated by rShh treatment. We chose Egr2 and Tox for
this experiment because both were expressed at very similar low
levels in WT and Gli3−/− in the CD69− DP dataset, but upregulated
in the CD69+ DP and SP4 populations. Furthermore, both
transcripts were significantly lower in the Gli3−/− CD69+ DP and
Fig. 5. See next page for legend.
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Gli3−/− SP4 datasets than in their WT counterparts, and these are
the populations that contain cells that are undergoing selection
(Fig. 7A,B). After 2 days of rShh treatment of WT E17.5 FTOC, the
levels of Egr2 and Tox were reduced compared with the untreated
control (Fig. 7C,D).
In the microarray data, we observed the same pattern of expression
for the known transcriptional target genes of TCR signal transduction,
Nr4a1 and Cd5 (Fig. 7E). Both were low in CD69− DP cells,
upregulated in the CD69+ DP population, and again in the SP4
population, but were significantly lower in the Gli3−/− CD69+ DP
and SP4 datasets than in WT. Thus, the differences in expression in
these genes only became apparent after TCR signalling for positive
selection, in support of the idea that Gli3mutation influences SP4 T-
cell development by increasing Shh, which signals to DP thymocytes
to dampen TCR signal transduction during positive selection.
Taken together, the transcriptome data suggest that cells
undergoing selection in the Gli3−/− thymus have a lower average
strength of TCR signal. To test this, we used canonical
correspondence analysis (CCA) to compare the patterns of gene
expression in our SP4 datasets with transcriptome data from
publically available datasets that were prepared from thymocytes
that were receiving different strengths of TCR signals during
selection (GSE38909; Lo et al., 2012). We selected the 1500 most
significant DEG genes from the GSE38909 dataset and used these to
generate a scale of strong toweak TCR signalling and plotted our SP4
datasets against this scale. This analysis showed that the SP4 Gli3−/−
samples have the transcriptional signature of thymocytes receiving a
lower TCR signal than those ofWT, whereas the transcriptome of the
SP4 population from the Gli3+/− thymus showed an intermediate
transcriptional signature (Fig. 7F). The CCA therefore confirms that
Gli3 is important for selection and differentiation from DP to SP4,
and is consistent with higher Shh expression dampening the TCR
signal during repertoire selection in the Gli3−/− thymus.
DISCUSSION
Here, we showed that expression of the transcription factor Gli3 in
TECs is necessary for normal differentiation from DP to mature SP4
thymocyte in the fetal thymus. Constitutive deletion of Gli3 reduced
differentiation and maturation of SP4 T-cells, and this reduction in
differentiation to SP4 was also seen when Gli3 was conditionally
deleted fromTECs only, but not whenGli3was conditionally deleted
from thymocytes. Gli3 repressed expression of Shh, and analysis of
an Hh reporter line showed that the Hh signalling pathway was active
in developing thymocytes, and that activation of the pathway in
thymocytes was increased when Gli3 was deleted. DP and SP
thymocyte populations from Gli3−/− had reduced levels of cell-
surface CD5, indicative of lower TCR signalling, and consistent with
the fact that rShh treatment of WT FTOC and constitutive activation
of Hh-mediated transcription both reduced cell-surface CD5
expression (Furmanski et al., 2012; Rowbotham et al., 2007).
Conditional deletion of Shh fromTECs increased differentiation from
DP to SP, whereas differentiation from DP to SP4 in the Gli3mutant
fetal thymus was restored by neutralisation of endogenous Hh
proteins. Taken together, our findings indicate that Gli3 activity in
TECs promotes SP4 T-cell development by repression of Shh, which
signals directly to developing T-cells to reduce TCR signal strength.
In support of this, the transcriptome data showed reduced expression
of genes important for TCR signalling and positive selection, and of
transcriptional targets of TCR signal transduction in the Gli3−/−
populations compared with their WT counterparts, whereas the WT
samples had decreased expression of Hh target and signalling genes.
Overall, the Gli3−/− SP4 cells had the transcriptional signature of
thymocytes that have received a weaker TCR signal than their WT
counterparts. The influence ofGli3mutation on the SP4 population is
consistent with this mechanism, as positive selection to the SP4
lineage requires stronger and longer TCR signals (Bosselut, 2004;
Klein et al., 2014; Starr et al., 2003).
Gli3 is expressed in fetal but not adult thymocytes (Hager-
Theodorides et al., 2005), and although conditional deletion ofGli3
from thymocytes did not significantly influence the proportions of
DP and SP populations, our experiments showed that Gli3 activity
in thymocytes is required for the normal interpretation of changes in
the Hh signal. In the constitutive Gli3−/− thymus, where increased
Shh signalling to developing thymocytes reduced differentiation
from DP to SP, although neutralisation of the Hh signal with rHhip
treatment was able to restore the proportion of the SP4 population, it
only significantly increased cell-surface expression of CD5 in the
CD3hi DP population. In contrast to the constitutive Gli3−/−
thymus, rHhip treatment in Gli3fl/fl FoxN1Cre+ FTOC increased
cell-surface CD5 expression on SP4 and CD3hi DP populations,
suggesting that the ability of developing fetal thymocytes to respond
to the decrease in the Shh signal upon rHhip treatment requires
thymocyte intrinsic Gli3 activity.
In summary, we showed that expression of the transcription factor
Gli3 by TECs is required for normal SP4 T-cell development in the
fetal thymus. As Gli3 deficiency increases Shh expression in the
thymus, and Hh plays a role in T-cell acute lymphoblastic leukaemia
(T-ALL), which arises in the thymus, it will be important to
investigate the impact of Gli3 activity in the thymic stromal
environment on T-ALL (Dagklis et al., 2016, 2015; González-
Gugel et al., 2013; Hou et al., 2014). It will also be important to
investigate the influence of Gli3 on shaping the TCR repertoire and in
autoimmunity.
Fig. 5. Neutralisation of Hh in Gli3fl/fl FoxN1Cre+ FTOC and conditional
deletion of Shh from TECs increase SP4 differentiation. (A-L) Flow
cytometry analysis with scatter plots showing relative mean±s.e.m., where
each point represents thymus from a different embryo. (A-E) E17.5 Gli3fl/fl
FoxN1Cre+ FTOC treated with rHhip for 4 days (n=7) compared with the
untreated lobe (control) from the same thymus (n=7). (A) CD8 against CD4.
(B) Percentage of thymocyte populations, showing significance by Student’s
t-test for rHhip treated versus control untreated for SP4 (P<0.02) and DN
(P<0.006). (C) The percentage of DP thymocytes, gated on CD3hi. The
difference in percentage of CD3hi DP cells between rHhip treated and control
was statistically significant by Student’s t-test (P<0.02). (D) CD8 versus CD4,
gated on CD3hi. (E) MFI of CD5 on rHhip-treated FTOC showing significance
by Student’s t-test versus control untreated FTOC for SP4 (P<0.02) and DP
(P<0.007). (F) Gated on CD3hi, MFI of CD5 on rHhip treated showing
significance by Student’s t-test versus control untreated FTOC for CD3hi SP4
(P<0.01) and CD3hi DP (P<0.02). (G-I) Flow cytometry of E17.5 FTOC +4 days
fromShhfl/fl FoxN1Cre− (n=4, control) and Shhfl/fl FoxN1Cre+ (n=6) littermates.
Scatter plots show relative mean±s.e.m., where each point represents thymus
from a different embryo. (H) Percentage of thymocyte populations and SP4:
SP8 ratio, in control and Shhfl/fl FoxN1Cre+, giving significance by Student’s
t-test compared with Cre− for SP4 (P<0.02), DP (P<0.04) and SP4:SP8 ratio
(P<0.05). (I) Percentage of thymocyte populations and SP4:SP8 ratio gated on
CD3hi, in control and Shhfl/fl FoxN1Cre+, giving significance by Student’s t-test
compared with Cre− for CD3hi SP4 (P<0.003) and CD3hi DP (P<0.002). (J-L)
E17.5 Shhfl/fl FoxN1Cre+ FTOC treated with 1 μg/ml rShh for 4 days compared
with control untreated Shhfl/fl FoxN1Cre+ FTOC thymus lobe from the same
thymus (n=5). (J) CD8 against CD4 staining (top); CD8 against CD4 staining,
gated on CD3hi (bottom). (K) Percentage of thymocyte population, divided by
the percentage from the control untreated cultured lobe from the same thymus,
giving significance compared with untreated for SP4 (P<0.04). (L) Percentage
of thymocyte population, gated on CD3hi, divided by the percentage from the
control untreated cultured lobe from the same thymus, giving significance
compared with untreated control for CD3hi DP (P<0.02) and CD3hi SP8
(P<0.03).
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Mice were on a C57BL/6 background. C57BL/6 mice were purchased from
Charles River; Gli3fl/fl, Gli3+/− and Shhfl/fl from The Jackson Laboratories;
GBS-GFP-tg was provided by J. Briscoe (Balaskas et al., 2012); Vav-iCre-
tg was provided by D. Kioussis (de Boer et al., 2003); and FoxN1Cre-tg by
G. Hollander (Zuklys et al., 2009). As FoxN1-Cre-tg and Vav-Cre-tg can be
expressed in the male germline, all conditional knockouts were generated by
crossing Cre+ females with Cre− males (Joseph et al., 2013; Shi et al.,
2016). Mice were bred and maintained at UCL under UK Home Office
regulations.
Flow cytometry, antibodies and cell purification
Thymus cell suspensions were prepared and stained as described (Hager-
Theodorides et al., 2005) using combinations of the following directly
conjugated antibodies at concentration of 1:100: (from BDPharmingen) anti-
γδPE (catalogue no. 553178); from eBioscience: anti-TCRβFITC (catalogue
no. 11-5961-85), antiCD3PE (catalogue no. 12-0031-82), anti-CD24PE
(catalogue no. 12-0241-82) and anti-CD69FITC (catalogue no. 11-0691-85);
(from Biolegend) anti-CD3FITC (catalogue no. 100204), anti-CD5FITC
(catalogue no. 100605), anti-Qa2FITC (catalogue no. 121709), anti-
CD4APC (catalogue no. 116014), anti-CD5PE (catalogue no. 100607),
anti-CD8PerCP/Cy5.5 (catalogue no. 100734), anti-CD4PerCP/Cy5.5
(catalogue no. 100539) and anti-CD8APC (catalogue no. 100712). Data
were acquired on a C6 Accuri flow cytometer (BD Biosciences) and analysed
using FlowJo software. Live cells were gated by FSC and SSC profiles. Data
represent at least three experiments.
Fetal thymus organ cultures
FTOCs were carried out as described (Saldaña et al., 2016). In some
experiments, rHhip or rShh (R&D Systems) was added at 1 µg/ml. To allow
comparison between litters for statistical analysis, relative numbers or
Fig. 6. Microarray datasets show
transcriptional differences in Hh
signalling genes and thymic
selection genes between E18.5 WT
and Gli3 mutant sorted CD69− DP,
CD69+ DP and SP4 populations.
(A) (Left) PCA axis 2 (PC2) for WT and
Gli3−/− CD69− DP, showing some
genes that contributed to the negative
(Gli3−/−) and positive (WT) PC2 axis.
(Right) Heatmap of DEGs identified by
intersection analysis between WT and
Gli3−/−CD69−DP. (B) (Left) PC3 forWT
and Gli3−/− CD69+ DP, showing some
genes that contributed to the negative
(Gli3−/−) and positive (WT) axis. (Right)
Heatmap of DEGs identified by
intersection analysis between WT and
Gli3−/−CD69+ DP. (C) (Left) PC2 for WT
and Gli3−/− SP4, showing some genes
that contributed to the negative (WT)
and positive (Gli3−/−) axis. (Right)
Heatmap of DEGs highlighted in
intersection analysis between WT and
Gli3−/− SP4.
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percentages for each genotype or treatment were calculated by dividing by
the mean of controls from the same litter (untreated control or WT
littermates).
Microarray and data analysis
E18.5WT,Gli3+/− andGli3−/− thymocytes (n=2) were stained for CD4, CD8
and CD69. SP4, CD69− DP and CD69+ DP populations were FACS sorted.
RNAwas extracted using the Arcturus PicoPure RNA Isolation kit (Applied
Biosystems) and quantity and quality determined by Bioanalyzer 2100
(Agilent).
Microarrays were performed by UCL Genomics on the Affymetrix
GeneChip Mouse Gene 2.0ST Array using standard Ambion (Invitrogen)
chemistry. Array data were normalised using the oligo package from R. Data
are publically available at GEO (GSE87499).
DEGs were determined using the moderated Ebayes t-statistic P<0.05 from
the limma package in Bioconductor. Principal component analysis (PCA) was
performed using normalised microarray transcript expression values, using the
CRAN package ade4. PCA is a multivariate statistical method, which can be
used to segregate genome-wide transcription datasets according to variability
in transcript expression values, taking into account all genes (Ringnér, 2008).
PCA can thus cluster microarray datasets to detect dominant patterns of gene
expression, as represented by the principal components (PCs).
Canonical correspondence analysis (CCA) is a multivariate analysis that
allows the comparison of experimental transcriptome data with publically
available datasets from other laboratories (Ono et al., 2014). CCA was
performed using the CRAN package vegan. The GSE38909 dataset was
used as the environmental variable and our dataset was regressed onto it. It
contains thymocytes stimulated with a positively selecting peptide gp250
and the non-selecting control peptide Hb (Lo et al., 2012). We created a
strong TCR signalling axis using the DEGs between the control peptide and
the positively selecting peptide and regressed our samples onto this axis
(Sahni et al., 2015).
Fig. 7. Microarray and QRT-PCR
analyses of transcriptional
differences in thymic selection
genes in sorted populations fromWT
and Gli3mutant thymus and in rShh-
treated WT FTOC. (A,B) Normalised
microarray transcript expression in
Gli3−/− andWTdatasets of (A)Egr2 and
(B) Tox. (C,D) QRT-PCR analysis
showing a representative experiment
(of three) for expression of (C) Egr2 and
(D) Tox in thymocytes prepared from
E17.5 WT control and rShh-treated
FTOCs for 2 days. Differences between
control and rShh treated were
significant: Egr2 (P<0.02), Tox
(P<0.07). Transcripts were normalised
relative to Hprt. (E) Normalised
microarray transcript expression in
Gli3−/− and WT datasets of Nr4a1 (top)
and Cd5 (bottom). (F) CCA showing the
separation of the WT,Gli3+/− (HET) and
Gli3−/− (KO) SP4 microarray datasets
on a scale of strong to weak TCR
stimulation.
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RNA extraction and cDNA synthesis were performed as described (Hager-
Theodorides et al., 2005). QRT-PCR, using QuantiTect primers for Egr2
and Tox (Qiagen) and iQSYBR Green Supermix (Bio-Rad), was run on an
iCycler (Bio-Rad). Transcripts were normalised relative to Hprt.
ELISA
Shh ELISAwas performed using the Shh N-Terminus Quantikine ELISA Kit
(R&D Systems). Entire E17.5 thymi were crushed and centrifuged at 3 g for 5
min, and ELISA was performed on the supernatants.
PCR for genotyping
DNA extraction and PCR were carried out using methods and primers
described previously (Hager-Theodorides et al., 2005; Saldaña et al., 2016).
Statistical analysis
Statistical analysis was performed using unpaired two-tailed Student’s
t-tests and P≤0.05 was considered significant. In figures: *P≤0.05,
**P≤0.01 and ***P≤0.001.
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Figure S1: Expression of TCRβ and TCRγδ in WT and Gli3-deficient E17.5+4 
Days FTOCs. 
(A) Histograms showing the expression of TCRβ, gated on SP4 cells from Gli3+/+ 
and Gli3-/-. (B) Scatter plot showing the percentage of TCRβ+ and TCRγδ+ cells in 
the SP4 population from Gli3+/+ and Gli3-/- (n=3). 
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Figure S2: Principal Component Analyses of E18.5 WT and Gli3-mutant facs-
sorted CD69-DP, CD69+DP and SP4 populations. 
PCA of the CD69-DP (A), the CD69+DP (C) and SP4 (E) datasets. Eigenvalues and 
percentage variability associated with each principal component for CD69-DP (B), 
the CD69+DP (D) and SP4 (F). 





















Table S1: Summary of intersected DEG and PCA genes annotated in the 
heatmap (Figure 6) of known relevant function. 
Gene 
Name 
Function in Thymus Reference 
TCR repertoire selection Genes
Egr1 Egr1 is rapidly upregulated after TCR 
stimulation and increased Egr1 
expression increases thymic selection. 
(Shao et al., 1997) 
Egr2 Egr2-deficiency impairs positive selection 
of both CD4 and CD8 SP thymocytes. It 
also upregulates survival molecule Bcl-2 
during positive selection allowing survival 
of positively selected thymocytes 
(Lauritsen et al., 
2008) 
Nab1 The Nab family members interact with the 
Egr1/2 to regulate different function in 
thymocytes and T cells. 
(Collins et al., 2008; 
Decker et al., 2003) 
Nab2 
Itk Itk is very importance for the efficient 
positive and negative selection of 
thymocytes. 
(Andreotti et al., 
2010) 
Tox TOX is important for the positive selection 
towards the CD4+ T cell lineage in the 
thymus 
(Aliahmad et al., 
2011) 
Lef1 LEF-1 is important for the positive 
selection of CD4 SP thymocytes from the 
DP stage. Lef1 directly induce the master 
regulator of CD4 lineage commitment, 
ThPok. 
(Steinke et al., 2014) 
Pten Loss of Pten leads to defects in negative 
selection  
(Suzuki et al., 2001) 
Socs1 Socs1 deficiency leads to impaired 
positive and negative selection in the 
thymus. Socs1 is important for CD4 T cell 
development. 
(Catlett and Hedrick, 
2005) 
Id2 Id2 and Id3 allow CD8+ T cell 
development 
(Jones-Mason et al., 
2012) 
Fas Fas-FasL interaction mediates activation-
induced cell death of mature postthymic T 
cells, allowing effective negative selection 
and elimination of autoimmune cells 
(Kishimoto and 
Sprent, 1997) 
CamK4 CaMK4 regulates the Ca2+-dependent 
gene transcription, and loss of CaMK4 in 
thymocytes impairs positive selection. 
(Raman et al., 2001) 
Cd6 Increase in CD6 expression allow DP 
thymocytes differentiate to a SPs.  
(Singer et al., 2002) 





















Cd53 CD53 expression is correlated with 
positive selection. DP thymocytes 
expressing CD53 are undergoing 
selection or have just undergone 
selection. 
(Puls et al., 2002) 
 TCR signal strength modulators 
Cd81 Loss of CD81 in thymocytes increases the 
TCR signal strength 
(Cevik et al., 2012) 
Cd5 High cell surface CD5 expression 
correlates with a stronger TCR signal and 
vice versa  
 (Azzam et al., 2001) 
Nr4a1  The expression of the Nr4a family 
member is also correlated with increases 
in TCR signal strength. 
(Moran et al., 2011; 
Nowyhed et al., 
2015) 
Nr4a3 
 Hedgehog Signalling and Target Genes 
Ihh Hedgehog protein expressed in DP cells  (Outram et al., 2009) 
Bmp2 Hedgehog signalling target involved in T-
cell development in thymus 
 (Hager-Theodorides 
et al., 2002; Outram 
et al., 2000) 
Hoxa7 Homeobox (Hox) family members are 
targets of Hedgehog signalling and 
interact with various Hh family members 
to control developmental processes. 
(Roberts et al., 1995) 
H19 Hh signaling increases H19 expression (Chan et al., 2014) 
Kif13b Kif13b promotes Shh signalling (Schou et al., 2017) 
Tgfb1 TGF-β-increases Shh signalling to 
induced fibrosis.  
(Chung and Fu, 
2013) 
Itgav Itgav is a target of Hedgehog signalling 
and can modulate Hedgehog signalling 
(Kosinski et al., 2010; 
Zhou et al., 2013) 
Aliahmad,	P.,	Kadavallore,	A.,	de	la	Torre,	B.,	Kappes,	D.,	Kaye,	J.,	2011.	TOX	is	required	for	development	of	the	CD4	T	cell	lineage	gene	program.	J	Immunol	187,	5931-5940.	Andreotti,	A.H.,	Schwartzberg,	P.L.,	Joseph,	R.E.,	Berg,	L.J.,	2010.	T-cell	signaling	regulated	by	the	Tec	family	kinase,	Itk.	Cold	Spring	Harb	Perspect	Biol	2,	a002287.	












































Table S2: PCA Gene list with relevant PC scores and Intersected Gene list for each 
sorted thymocyte population.
Click here to Download Table S2
Development 145: doi:10.1242/dev.146910: Supplementary information
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